Bioventus (NYSE:BVS) PT Raised to $17.00
Bioventus (NYSE:BVS – Free Report) had its price target hoisted by Craig Hallum from $12.00 to $17.00 in a research note issued to investors on Friday morning, Benzinga reports. Craig Hallum currently has a buy rating on the stock. Separately, Canaccord Genuity Group raised their price target on shares of Bioventus from $8.00 to $12.00 […]
1 Oct 02:30 · The Cerbat Gem